Community Webinar: Rhabdomyolysis in Duchenne

February 20, 2024 1:00PM

Join Jett Foundation’s Community Webinar Series on February 20 at 1PM EST to hear from Dr. Carla Zingariello on Rhabdomyolysis in Duchenne muscular dystrophy, a medical condition that occurs when damaged muscle tissue releases its proteins and electrolytes into the blood (Center for Disease Control, 2024).

Rhabdomyolysis in Duchenne
Tuesday, February 20, 2024
1pm ET | 12pm CT | 11am MT | 10am PT


Dr. Carla Zingariello, DO

Guest Speaker

Dr. Zingariello completed her Pediatric Neurology residency at Vanderbilt, followed by a Neuromuscular fellowship at the University of Pennsylvania/CHOP. She joined the Child Neurology faculty at the University of Florida in 2018 and participates in the MDA clinic at UF. 

Dr. Zingariello is actively involved in muscular dystrophy research. Since 2022, she has served as Co-PI on a CDC-sponsored muscular dystrophy surveillance study (MD STARnet). She also serves as PI for a Limb Girdle muscular dystrophy clinical trial. She additionally serves as a sub-Investigator on multiple gene therapy clinical trials for Duchenne muscular dystrophy.

Community Webinar Series - Better preparing for challenges in Duchenne

Our Community Webinar Series is focused on ensuring that our Duchenne community is better prepared for those unexpected moments, challenging medical decisions, and difficult stages when on a Duchenne journey.

No one ever expects Duchenne and there is no correct way to tackle a diagnosis, but we can always better prepare. This webinar series is an opportunity to equip yourself with more knowledge, resources, and tools for those real-life, often unanticipated, scenarios.

Experience the magic this summer!

How is the rare disease community accomplishing goals?

Tune in on February 29 to hear from our panel and moderators on how they are accomplishing goals and living life to the fullest!

Your gift helps Jett Foundation provide programming and opportunities, such as Camp Promise, to many families impacted by Duchenne muscular dystrophy each year.

Accessible Vehicle Fund Applications Open